Dermatologic adverse events of brentuximab vedotin: Characteristics, management, and their relationship with dose regimen Meeting Abstract


Authors: Oh, Y.; Bang, A.; Kurtansky, N.; Khan, N.; Pulitzer, M.; Noor, S.
Abstract Title: Dermatologic adverse events of brentuximab vedotin: Characteristics, management, and their relationship with dose regimen
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120601225
DOI: 10.1200/JCO.2021.39.15_suppl.3049
PROVIDER: wos
Notes: Meeting Abstract: 3049 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Melissa P Pulitzer
    203 Pulitzer
  2. Sarah J Noor
    41 Noor
  3. Niloufer Khan
    48 Khan
  4. Yuna Oh
    12 Oh
  5. Alexander Bang
    17 Bang